Video: Lynne McGrath of Novartis on commitment to developing treatments for #RareDisease

Lynne McGrath of novartis on rare disease and orphan drugs Lynne McGrath, Vice President, US DRA Head of Oncology at Novartis, presented at last year's World Orphan Drug Congress USA on the topic ‘A commitment to develop innovative treatments for neglected diseases.'

Do you want to learn more about:

  • Setting up NIBR regardless of market size
  • Expanding application to common diseases
  • Transforming a promising candidate drug into a treatment reality that benefits patients

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!

Leave a Reply

Your email address will not be published. Required fields are marked *